Antioxidant and inflammatory status in lung cancer patients: systemic or local correlation? Source: Eur Respir J 2006; 28: Suppl. 50, 769s Year: 2006
The interrelation between inflammation markers and protease-antiprotease status in blood serum in patients with stable COPD Source: Annual Congress 2007 - Pathophysiology and assessment of COPD Year: 2007
The estimation of adaptation of functional systems of the patients with a lung cancer and secondary inflammatory changes Source: Eur Respir J 2006; 28: Suppl. 50, 751s Year: 2006
Role of systemic and bronchial oxidative stress and inflammation in lung cancer predisposition in patients with COPD Source: Annual Congress 2011 - Biomarkers and other new methods for lung cancer Year: 2011
Role of systemic and muscle oxidative stress and cytokines in patients with lung cancer cachexia Source: Annual Congress 2011 - Physiological basis of respiratory disease Year: 2011
Is there any correlation between blood neutrophil inflammatory biochemical markers and lung function impairment in COPD patients? Source: Eur Respir J 2003; 22: Suppl. 45, 85s Year: 2003
Relationships between inflammatory markers, response to therapy, and lung function decline Source: International Congress 2017 – Heterogeneity in COPD inflammation: implications for therapy and clinical outcomes Year: 2017
Oxidant- antioxidant balance in lung cancer: is there any prognostic correlation? Source: Eur Respir J 2003; 22: Suppl. 45, 251s Year: 2003
Alterations of serum inflammatory biomarkers in the healthy and lung cancer patients before and post chemotherapy Source: Annual Congress 2012 - New biomarkers for lung cancer Year: 2012
The clinicofunctional features of patients with lung cancer and secondary inflammatory changes Source: Eur Respir J 2006; 28: Suppl. 50, 782s Year: 2006
The link between inflammation and cancer Source: International Congress 2018 – Scientific Year in Review Year: 2018
Parameters of antioxidant protection in patients with lung sarcoidosis Source: Annual Congress 2009 - Mechanisms of pulmonary inflammation and fibrosis Year: 2009
Reduced anti-oxidant and increased inflammatory status in interstitial lung diseases (ILD) Source: Eur Respir J 2007; 30: Suppl. 51, 110s Year: 2007
The effects of antioxidant therapy on lung clearance, pulmonary function test and oxidant stress in patients with COPD Source: Eur Respir J 2002; 20: Suppl. 38, 258s Year: 2002
The terms of adaptation of functional systems of patients with lung cancer and secondary inflammatory changes after surgical treatment Source: Eur Respir J 2006; 28: Suppl. 50, 750s Year: 2006
Nutritional modulation to correct metabolic alterations in chronic lung disease Source: ERS Lung Science Conference 2020 Year: 2020
Impaired lung function is associated with systemic inflammation and macrophage activation Source: Eur Respir J 2015; 45: 557-559 Year: 2015
Relation between physical capacity, nutritional status and systemic inflammation in COPD patients Source: Annual Congress 2008 - Functionality and metabolism in rehabilitation candidates Year: 2008
Role of altered level of oxidant-antioxidant in disease prognosis of asthma Source: Annual Congress 2012 - Cell biology and inflammatory gene expression in chronic lung disease Year: 2012
Relationship between markers of systemic inflammation and microstructural brain damage in COPD. Source: International Congress 2019 – From the health effects of tobacco to the epidemiology of tobacco/electronic nicotine delivery system use Year: 2019